参考文献/References:
[1] Nishikimi T，Kuwahara K，Nakao K.Current biochemistry， molecular biology，and clinical relevance of natriuretic peptides[J].J Cardiol，2011，57（2）：131-140.
[2] Kim HN，Januzzi JL Jr.Natriuretic peptide testing in heart failure[J].Circulation，2011，123（18）：2015-2019.
[3] 陈玲.脑钠肽临床研究新进展[J].华北煤炭医学院学报，2009，
11（3）：328-329.
[4] 潘晔生，魏盟.脑钠肽临床应用进展[J].心血管病学进展，2007，
28（5）：799-802.
[5] Maisel AS，Krishnaswamy P，Nowak RM，et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med，2002，347（3）：161-167.
[6] Kapoun AM，Liang F，O'young G，et al.B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts：fibrosis，myofibroblast conversion，proliferation，and inflammation[J].Circ Res，2004，94（4）：453-461.
[7] Sugisawa T，Kishimoto I，Kokubo Y，et al.Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes[J].Diabetes Res Clin Pract，2010，89（2）：174-180.
[8] Chang HR，Hsieh JC，Hsu BG，et al.Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure[J].PLoS One，2013，8（11）：e79096.
[9] Collins S.A heart-adipose tissue connection in the regulation of energy metabolism[J].Nat Rev Endocrinol，2014，10（3）：157-163.
[10] Moro C，Lafontan M.Natriuretic peptides and cGMP signaling control of energy homeostasis[J].Am J Physiol Heart Circ Physiol，2013，304（3）：H358-H368.
[11] Vila G，Grimm G，Resl M，et al.B-type natriuretic peptide modulates ghrelin，hunger，and satiety in healthy men[J].Diabetes，2012，61（10）：2592-2596.
[12] Lazo M，Young JH，Brancati FL，et al.NH2-terminal pro-brain natriuretic peptide and risk of diabetes[J].Diabetes，2013，62（9）：3189-3193.
[13] Miyashita K，Itoh H，Tsujimoto H，et al.Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity[J].Diabetes，2009，58（12）：2880-2892.
[14] Oztekin S，Karakurt O，Yazihan N，et al.Relationship of brain natriuretic peptide with metabolic syndrome parameters：an obser-vational study[J].Anadolu Kardiyol Derg，2011，11（8）：678-684.
[15] Shivananda Nayak B，Teelucksingh S，Jagessar A，et al.A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad，West Indies[J].Diabetes Metab Syndr，2013，7（1）：8-11.
[16] Heinisch BB，Vila G，Resl M，et al.B-type natriuretic peptide （BNP） affects the initial response to intravenous glucose：a randomised placebo-controlled cross-over study in healthy men[J].Diabetologia， 2012，55（5）：1400-1405.
[17] Gruden G，Landi A，Bruno G.Natriuretic peptides，heart，and adipose tissue：new findings and future developments for diabetes research[J].Diabetes Care，2014，37（11）：2899-2908.
[18] Rizzo NO，Maloney E，Pham M，et al.Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding[J].Arterioscler Thromb Vasc Biol，2010，30（4）： 758-765.
[19] Handa P，Tateya S，Rizzo NO，et al.Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding[J].Arterioscler Thromb Vasc Biol，2011，
31（12）：2827-2835.
[20] Magnusson M，Jujic A，Hedblad B，et al.Low plasma level of atrial natriuretic peptide predicts development of diabetes：the prospective Malmo Diet and Cancer study[J].J Clin Endocrinol Metab，2012，97（2）：638-645.
[21] Park K，Itoh H，Yamahara K，et al.Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases[J].Endocrinology，2008，149（2）：483-491.
[22] Shmilovich H，Ben-Shoshan J，Tal R，et al.B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells[J].Tissue Eng Part A，2009，15（9）：2741-2749.
相似文献/References:
[1]李建薇,田浩明.肝X受体与代谢综合征[J].国际内分泌代谢杂志,2007,(04):252.
[2]赵娅,万沁.类胰蛋白酶与代谢综合征[J].国际内分泌代谢杂志,2015,(03):190.[doi:10.3760/cma.j.issn.1673-4157.2015.03.013]
Zhao Ya,Wan Qin..Tryptase and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(02):190.[doi:10.3760/cma.j.issn.1673-4157.2015.03.013]
[3]肖艳新,边志颖,赵新翠,等.代谢综合征患者血清色素上皮衍生因子水平变化的研究[J].国际内分泌代谢杂志,2016,36(06):366.[doi:10.3760/cma.j.issn.1673-4157.2016.06.02]
Xiao Yanxin*,Bian Zhiying,Zhao Xincui,et al.Changes of serum pigment epithelium-derived factor in patients with metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(02):366.[doi:10.3760/cma.j.issn.1673-4157.2016.06.02]
[4]盘庆飞,黄贤,李圣海.两种代谢综合征诊断标准在高血压
人群中的比较[J].国际内分泌代谢杂志,2017,37(02):86.[doi:10.3760/cma.j.issn.1673-4157.2017.02.004]
Pan Qingfei,Huang Xian,Li Shenghai..Comparison of the two diagnostic criteria of metabolic syndrome among hypertensive population[J].International Journal of Endocrinology and Metabolism,2017,37(02):86.[doi:10.3760/cma.j.issn.1673-4157.2017.02.004]
[5]扬,徐书杭,黄华英,等.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
iao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(02):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[6]应昉曹璐陈凤 许帅陈风郭妍王岩王涤非undefined.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10. 3760/cma. j. issn. 1673-4157. 2020. 01.002]
Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community eld erly residents[J].International Journal of Endocrinology and Metabolism,2020,40(02):5.[doi:10. 3760/cma. j. issn. 1673-4157. 2020. 01.002]